BY: CLAIRE KIM
“On Monday clinics around the country began a Phase 3 trial of the vaccine candidate from Moderna, a biotech company based in Massachusetts, with the aim of enrolling 30,000 people to test for safety and effectiveness.” (New York Times)
Currently, the coronavirus vaccine, Moderna, is undergoing the Phase 3 examination period, a phase that demands over 1,000+ people to participate and show positive results.
If a vaccine “in the works” enters the Phase 3 trial, this is a good sign. For vaccine testing, at least, the Phase 3 trial is the last stage before a drug is submitted for FDA approval, which, if successfully passed, usually suggests that it is an effective drug for the market.
If anything, within a couple of months, we might have a functioning vaccine in our hands. The pandemic that we are living in might be over, and this is an exciting prospect.
For more detailed news about the Moderna vaccine, check out this link of a New York Times Article: Moderna Vaccine Test in Monkeys Shows Promise